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lassa fever to other common infectious diseases, and few number
of diagnostic facilities
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o-infection of Epstein-Barr virus (EBV) with high risk Human
apillomavirus (HR-HPV) is a signiﬁcant risk of cervical cancer
. Aromseree1,∗, C. Pientong1, N. Sunthamala1, P. Swangphon1,
. Chaiwongkot1, B. Kongyingyoes2, N. Patarapadungkit3, B.
humworathayee4, T. Ekalaksananan1
Department ofMicrobiology, Faculty ofMedicine, Khon KaenUniver-
ity, Khon Kaen, Thailand
Department of Pharmacology, Faculty of Medicine, Khon Kaen Uni-
ersity, Khon Kaen, Thailand
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Background: Cervical cancer is the 2nd most common can-
er among women in developing countries and well known to be
aused by HPV infection. However, only small percentage of HPV
nfected women develop cervical cancer, therefore other cofactors
ncluding sexual transmitted infectious agents may inﬂuence the
isease development. This study aimed to investigate the associa-
ion of EBV co-infection with HPV in cervical lesion.
Methods:HPVandEBVDNA in cervical tissueswere detected by
olymerase chain reaction (PCR). HPV genotypes were determined
y reverse line blot hybridization assay and HPV physical status
as investigated by the ampliﬁcation of papillomavirus oncogene
ranscripts (APOT) assay. Data were analyzed by SPSS 13.0.
Results: The presence of EBV DNA in no squamous intraepithe-
ial lesion (noSIL), low grade SIL (LSIL), high grade SIL (HSIL) and
ervical carcinoma (CA) groupswere 37.50% (12/32), 14.29% (5/35),
0.00% (27/45) and38.71% (12/31), respectivelywhile theHPVDNA
ere detected in 43.75% (14/32), 45.71% (16/35), 82.22% (37/45)
nd 93.55% (29/31), respectively. All of 143 cases, co-infections of
PV and EBV were detected in 39 cases and more frequently found
n HSIL/CA group than in noSIL/LSIL (p < 0.05, OR = 5.081). Each
enotype of HR-HPV infection in HSIL/CA group (HPV16, 33, 35, 39,
5 and 58) were found to be co-infected with EBV more than 45%.
his co-infection pattern was not found in noSIL/LSIL group. For
nvestigation of HPV physical status, the result showed that EBV
o-infection in noSIL/LSIL group was associated with HPV infec-
ion with only episomal form. Interestingly, in HSIL/CA group, EBV
o-infection was found in both episomal and integration form of
PV infection. EBV co-infection with HPV episomal form (35.48%)
s signiﬁcantly higher than HPV-alone infection (11.43%), whereas
ith integration form, HPV-alone infection (28.57%) is higher but
o signiﬁcant difference when compared to HPV-EBV co-infection
12.90%).
Conclusion: This study demonstrated that EBV-HPV co-
nfections, especially with HR-HPV were signiﬁcantly increased in
SIL/CA groups. Interestingly, this co-infection was not associated
ith HPV integration but raised the possibility that EBV could be
possible cofactor and induce HPV episomal form to contribute to
ervical cancer development.
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Background: Lassa fever (LF), is an acute viral haemorrhagic
fever that has assumed epidemic proportions in many parts of
Nigeria. During epidemics, the case fatality rate may be up to 50%
or more. Unfortunately the diagnosis and clinical management of
lassa fever poses great challenge due to the fact that early symp-
toms of the disease are often indistinguishable from that of malaria
which is also endemic in West Africa and the diagnostic challenges
posed by the requirement for highly sophisticated diagnostic tech-
nique, which is unavailable in over 90% of the health facilities in
Nigeria.
Methods: Over a three year period the Lassa Fever practice
at the Irrua Specialist Hospital (ISTH), Nigeria was documented.
All the clinically suspected cases of LF admitted to ISTH between
September2008andSeptember2011were reviewed.Onlypatients
who satisﬁed the clinical criteria for the diagnosis of LF, were
included in the review. Laboratory diagnosis was by RT-PCR. Chal-
lenges experienced in the treatment (drug administration) and
clinical management of atypical presentations and complications
of the diseases are discussed and the outcome variables presented.
SPSS version 12 was used for statistical analysis
Results:Overall case fatality rate (CFR)was 35.8%. CFR increased
with increasing delay before presentation. It was 56.3% at 14 or
more days before presentation. Challenges with diagnosis include
need for a high index of suspicion for clinical diagnosis, as most
patients present with symptoms similar to malaria or other com-
mon causes of fever. Drug administration with Ribavirin poses
signiﬁcant stress to the physician as it requires the use of sev-
eral ampoules of the drug, often between 20 -50 ampoule or more
depending on the weight of the patient. At ISTH we have partially
overcome this dilemma by giving the loading doses of 100mg/kg
and 25mg/kg respectively over 5days rather than the conventional
textbook recommendation. Presently we have observed only 2
cases of Non response to Ribavarin.
Conclusion: Lassa fever practice challenges in Nigeria include
the initial difﬁculty in making diagnosis because of similarity of
